Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.68 |
| ▸ | XPO1 | O14980 | 2/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.68 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.68 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | PRKCG | P05129 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | PRKCB | P05771 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30158338 | 0.88 | MAOA (0.78) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| SCHEMBL24075636 | 0.88 | MAOA (0.78) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| SCHEMBL12299958 | 0.85 | PTGS1 (0.74) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| SCHEMBL17194876 | 0.82 | PTGS1 (0.70) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| SCHEMBL29074526 | 0.81 | SRD5A1 (1.00) | PTGS1MAOASRD5A1ALDH1A1CYP3A4 | |
| Osthole SCHEMBL50436 | 0.81 | PTGS2 (1.00) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| Osthole SCHEMBL17513161 | 0.81 | PTGS2 (1.00) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| Osthole SCHEMBL29595542 | 0.81 | PTGS2 (1.00) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| SCHEMBL24337416 | 0.81 | MAOA (0.68) | PTGS1MAOASRD5A1XPO1PTGS2 | |
| Osthole SCHEMBL27681201 | 0.80 | PTGS2 (0.97) | PTGS1MAOASRD5A1XPO1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105555287-A | Plant-based ketohexokinase inhibitors for supporting weight management | ACCESS BUSINESS GROUP INT LLC | 2016-05-04 | — | — | CN | claimed |
| EP-3010520-A1 | PLANT-BASED INHIBITORS OF KETOHEXOKINASE FOR THE SUPPORT OF WEIGHT MANAGEMENT | Access Business Group International LLC (US) | 2016-04-27 | — | — | EP | claimed |
| US-20140377386-A1 | PLANT-BASED INHIBITORS OF KETOHEXOKINASE FOR THE SUPPORT OF WEIGHT MANAGEMENT | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2014-12-25 | — | — | US | claimed |
| WO-2014204853-A1 | PLANT-BASED INHIBITORS OF KETOHEXOKINASE FOR THE SUPPORT OF WEIGHT MANAGEMENT | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2014-12-24 | — | — | WO | claimed |
| WO-2009052518-A2 | METHODS AND COMPOSITIONS DIRECTED TO REDUCTION OF FACIAL HAIR HIRSUTISM IN FEMALES | ASPEN BENEFITS GROUP, LLC (US) | 2009-04-23 | — | — | WO | claimed |
| CN-101362768-A | Separation and purification method of monomeric compound in root of dahurain angelica | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2009-02-11 | — | — | CN | claimed |
| CN-1163760-A | Health food containing active component of Tianshishan ginseng and Chinese angelica plant | DONG FAMING (CN) | 1997-11-05 | — | — | CN | claimed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250177348-A1 | Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2025-06-05 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| CN-118028256-B | Cnidium hydroxylase gene CmC '2' H and application thereof | 皖西学院 | 2025-01-21 | — | — | CN | disclosed |
| US-12161621-B2 | Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2024-12-10 | — | — | US | disclosed |
| US-6737084-B2 | Compositions and methods for enhancing or treating female sexual response | QUALILIFE | 2004-05-18 | — | — | US | disclosed |
| WO-2004022080-A2 | BUGUZHI AGENT AND COMPOSITION AND METHODS OF PREPARING AND ADMINISTERING THE SAME | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-18 | — | — | WO | disclosed |
| US-20040043089-A1 | Buguzhi agent and composition and methods of preparing and administering the same | UNIVERSITY OF HONG KONG, THE (CN) | 2004-03-04 | — | — | US | disclosed |
| EP-1328281-A1 | COMPOSITIONS AND METHODS FOR TREATING FEMALES SEXUAL RESPONSE | Qualilife Pharmaceuticals Inc. (US) | 2003-07-23 | — | — | EP | disclosed |
| US-20020034557-A1 | Compositions and methods for treating female sexual response | SEMPRAE LABORATORIES, INC. | 2002-03-21 | — | — | US | disclosed |
| WO-2002000240-A2 | COMPOSITIONS AND METHODS FOR TREATING FEMALES SEXUAL RESPONSE | QUALILIFE PHARMACEUTICALS INC. (US) | 2002-01-03 | — | — | WO | disclosed |
| CN-1163760-A | Health food containing active component of Tianshishan ginseng and Chinese angelica plant | DONG FAMING (CN) | 1997-11-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12161621-B2 | Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease | KHK, GCK, FN3K | PTGS1 1692/4885MAOA 1660/4885SRD5A1 3631/4885 |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | PTGS1 4638/4885MAOA 471/4885SRD5A1 1544/4885 |
| US-20140377386-A1 | PLANT-BASED INHIBITORS OF KETOHEXOKINASE FOR THE SUPPORT OF WEIGHT MANAGEMENT | KHK, GCK, HK1 | PTGS1 2524/4885MAOA 2312/4885SRD5A1 3617/4885 |
| US-20250177348-A1 | Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease | KHK, GCK, FN3K | PTGS1 2221/4885MAOA 1165/4885SRD5A1 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.